High BMI: Another Barrier to Rapid Platelet Inhibition After STEMI PCI

Cardiovasc Drugs Ther. 2024 Feb;38(1):9-11. doi: 10.1007/s10557-023-07504-6. Epub 2023 Aug 18.

Authors

Kenneth M Zabel¹, James C Blankenship²

Affiliations

¹ Department of Internal Medicine, University of New Mexico Health Sciences Center, MSC 10 5550, 1 University of New Mexico, Albuquerque, NM, 87131, USA.
² Division of Cardiology, University of New Mexico Health Sciences Center, MSC 10 5550, 1 University of New Mexico, Albuquerque, NM, 87131, USA. jblankenship@salud.unm.edu.

PMID: 37594651
DOI: 10.1007/s10557-023-07504-6

No abstract available

Publication types

Editorial

MeSH terms

Blood Platelets
Body Mass Index
Humans
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors / adverse effects
ST Elevation Myocardial Infarction* / diagnosis
ST Elevation Myocardial Infarction* / therapy
Treatment Outcome

Substances

Platelet Aggregation Inhibitors